We report the first two cases of adult-onset type II
citrullinemia (CTLN2) successfully treated by
liver transplantation from deceased donors in Japan. One patient was a 34-year-old female, who had suffered from depression since the age of 28 years and developed consciousness disturbance at 34 years old. The other patient was a 41-year-old man who began to experience consciousness disturbance with abnormal behavior at 37 years old. Both patients were first treated with non-surgical
therapies, including
low-carbohydrate diet,
arginine granules and
sodium pyruvate. However, their therapeutic efficacy was limited and attacks of
encephalopathy occurred frequently with elevation of plasma
ammonia despite treatment. While both patients and their families desired
liver transplantation, no candidate donors for live-donor
liver transplantation were available. Fortunately, within a relatively short period after enrollment for
liver transplant from deceased donors in Japan (13 and 43 days, respectively), they underwent cadaveric
liver transplantation. The clinical courses after the operation were uneventful in both cases and no attacks of
hepatic encephalopathy have occurred. Although there have been no reports of good
therapies for CTLN2 patients with resistance to non-surgical
therapies and no live-donor candidates, our observations indicate that cadaveric
liver transplantation can be a promising therapeutic option for CTLN2 patients.